Success Metrics

Clinical Success Rate

50.0%

Based on 2 completed trials

Completion Rate

50%(2/4)

Active Trials

2(33%)

Results Posted

50%(1 trials)

Terminated

2(33%)

Phase Distribution

Ph not_applicable

33%

Ph phase_3

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 3Large-scale testing

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Terminated(2)

Detailed Status

Completed2

Terminated2

Active, not recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (33.3%)

N/A2 (66.7%)

Trials by Status

active_not_recruiting117%

recruiting117%

completed233%

terminated233%

Recent Activity

2 active trials

Showing 5 of 6

active_not_recruitingnot_applicable

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

NCT00542373

recruiting

Clinical Trials (6)

Showing 6 of 6 trials

NCT00542373Not Applicable

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

Active Not Recruiting

NCT00898235

Collection of Samples and Clinical Data From Patients With Amyloid Diseases

Recruiting

NCT00507182Not Applicable

Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions

Completed

NCT00529464Phase 3

Spectroscopy Versus Standard Care in Cervical Cancer Patients

Terminated

NCT00918216

Spectroscopy of Breast Tissue

Completed

NCT00488332

An Exploratory Study on Optical Assessment of Oral Mucositis

Terminated

All 6 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 6